Trapelo Health's services include information on the analysis of cancerous tissues and the generation of a genomic picture of genes and corresponding molecular pathways, enabling oncologists to access and consider medical evidence to support molecular diagnostics and targeted therapeutics. By providing real-time, evidence-based information and full transparency, Trapelo helps oncologists make patient-based decisions with reimbursement assurance from the start. Trapelo Health is dedicated to giving patients the best possible chance in their battle with cancer by aligning the interests of oncologists, molecular labs, and payers in the appropriate, scalable use of precision medicine.